Weighted TOPSIS

  • 文章类型: Journal Article
    如何全面评估药物使用的合理性是一个具有挑战性的问题。
    建立tislelizumab有效使用的评价指标,从而保证其在临床应用中具有较高的合理性和规范性。
    根据指示,药物说明,和《国家基本医疗保险限制目录》的相关指南,我们对2022年1月至12月在我院使用tislelizumab注射液的286例患者进行了回顾性分析和评价,这些患者采用加权技术按相似度-理想解(TOPSIS)的偏好顺序法.
    在评估的286个病历中,主要的非理性表现是不适当的适应症(90例,31.47%),辅助检查和实验室检查不符合联合化疗药物的最低要求(40例,13.99%),药物疗程不规范(39例,13.64%)。在包括的案件中,57.34%是合理的情况(Ci^0.8),10.84%为基本合理案例(0.6Ci<0.8),不合理病例占31.82%(Ci<0.6)。
    TOPSIS方法,利用其属性层次模型(AHM)加权方法,可用作Tislelizumab注射的合理评估技术。tislelizumab在我院的临床应用仍然不足,这需要进一步改进管理。
    UNASSIGNED: How to comprehensively evaluate the rationality of drug use is a challenging issue.
    UNASSIGNED: To establish the evaluation index of the effective use of tislelizumab, so as to ensure its higher rationality and normalization in clinical application.
    UNASSIGNED: Based on the indications, drug instructions, and relevant guidelines of the National Basic Medical Insurance Restriction Catalogue, a retrospective analysis and evaluation of 286 cases of using tislelizumab injection in our hospital from January to December 2022 were conducted using the weighted technique for order of preference by similarity to ideal solution (TOPSIS) method.
    UNASSIGNED: Among the 286 medical records evaluated, the main irrational manifestations were inappropriate indications (90 cases, 31.47%), auxiliary examination and laboratory examination did not meet the minimum requirements of combination chemotherapy drugs (40 cases, 13.99%), the drug course was not standard (39 cases, 13.64%). Among the included cases, 57.34% were reasonable cases (Ci⩾ 0.8), 10.84% were basic reasonable cases (0.6 ⩽Ci< 0.8), and 31.82% were unreasonable cases (Ci< 0.6).
    UNASSIGNED: The TOPSIS method, with its attribute hierarchical model (AHM)-weighted approach, can be employed as the rational assessment technique for the injection of tislelizumab. The clinical application of tislelizumab in our hospital is still insufficient, which needs to be further improved management.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    作为中国经济强省和人口大省,江苏有四种地方病。尽管在过去的十年中做出了努力,由于这四种地方病的病因链和影响因素的不同,这四种地方病的预防和控制不统一。在地方病控制的评价方法中,目前每种疾病只有一种方法可用。在这项研究中,选取14项指标对2013-2022年江苏省地方病控制效果进行综合评价。对指标权重的计算方法进行了改进,建立了基于相似度的最优解模型和加权灰色关联分析模型的模糊综合评价模型。综合评价结果显示,江苏地方病防治工作的进展并不总是符合我们改善的预期,2015年、2013年、2021年、2022年和2014年出现了前五年更好的控制。敏感性分析的结果证实了这些发现的可靠性和准确性。我们发现盐业改革等措施,使用甲状腺超声,和新建居民供水工程影响了江苏地方病防治的进展。地方病状况的跟踪应考虑其他行业实施的政策变化对地方病预防和控制的潜在影响。此外,本研究结果为我国其他地区加强防控措施提供了理论依据。
    As a strong economic and populous province in China, Jiangsu is home to four endemic diseases. Despite efforts in the past decade, the prevention and control of these four endemic diseases are not uniform because of the different etiological chains and influencing factors of these diseases. Among the evaluation methodologies for endemic disease control, only one method is currently available for each disease. In this study, we selected 14 indicators to comprehensively evaluate the effectiveness of endemic disease control in Jiangsu between 2013 and 2022. We improved the method for calculating the weights of the indicators and established a fuzzy comprehensive evaluation model based on the weighted Technique for Order Preference by Similarity to an Ideal Solution model and a weighted grey relational analysis model. The results of the comprehensive evaluation showed that the progress of endemic disease control in Jiangsu was not always in line with our expectations of improvement, with the top five years of better control occurring in 2015, 2013, 2021, 2022, and 2014. The results of the sensitivity analysis confirm the reliability and accuracy of these findings. We discovered that measures such as the reform of the salt industry, use of thyroid ultrasound, and new water supply projects for residents in Jiangsu affected the progress of endemic disease prevention and control. The tracking of endemic disease status should consider the potential effects of changes in policies implemented in other industries on endemic disease prevention and control. Additionally, the results of this study provide a theoretical basis for enhancing prevention and control practices in other regions of China.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    儿童健康是中国重要的公共卫生问题,中国政府一直高度重视儿童保健。随着近几十年来我国一系列医疗卫生改革的实施,儿童健康状况逐年改善。目的综合评价近年来我国医疗卫生改革措施是否有效促进了我国儿童保健事业的发展,为今后我国儿童保健政策的决策提供理论支持。方法从《中国卫生统计年鉴》中选取6项指标。基于多准则决策分析(MCDA)算法,研究中应用了三种不同的评价方法,它们是通过与理想解(TOPSIS)方法相似来进行订单偏好的加权技术,加权秩和比(RSR)方法,和模糊综合评价(FCE)。通过熵权法客观地计算了各指标的权重。进行了敏感性分析,以验证排名结果的稳定性和准确性。结果不同评价方法计算的各年儿童保健等级值不完全相同,但总体趋势是一致的,从2000年到2020年,中国的儿童保健水平逐年提高。前5名是2016-2020年的排名,后5名是2000-2004年的排名。结论医疗卫生改革实施的政策措施,以及改善卫生条件,健康食物和水的供应,等。,在过去的20年里,共同促进了中国儿童保健的发展,为今后促进儿童保健的政策制定提供科学的理论依据。
    Child health is an important public health issue in China and the Chinese government always attached great importance to child health care. With the implementation of a series of medical and health reforms in China in recent decades, the status of child health improved year by year. Objectives This study aims to comprehensively evaluate if the measures implemented in the medical and health reforms effectively promoted the development of Chinese child health care in recent years and provide theoretical support for future decision-making on the policies of child health care in China. Methods A total of six indicators were selected from the China Health Statistics Yearbook. Based on the multi-criteria decision analysis (MCDA) algorithm, three different evaluation methods were applied in the study, which are the weighted technique for order preference by similarity to an ideal solution (TOPSIS) method, the weighted rank-sum ratio (RSR) method, and the fuzzy comprehensive evaluation (FCE). Each indicator\'s weight was calculated by the entropy weight methods objectively. The sensitivity analysis was conducted to validate the stability and accuracy of the rank results. Results The results indicated that the rank values of each year\'s child health care calculated by the different evaluation methods were not exactly the same, but the overall trend is consistent which is that child health care in China improved year by year from 2000 to 2020. The top 5 were ranked from 2016-2020 and the bottom 5 were ranked from 2000-2004. Conclusions The results indicated that the policies and measures implemented in the medical and health reforms, as well as improved sanitation conditions, availability of healthy food and water, etc., have jointly promoted the development of child health care in China in the past 20 years, providing a scientific theoretical basis for future policy-making to promote child health care.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号